Keynote-158 study, FDA granted accelerated approval of pembrolizumab for the treatment of patients with advanced PD-L1-positive cervical cancer

被引：31
作者：
Borcoman, Edith [1 ,2 ]
Le Tourneau, Christophe [1 ,2 ,3 ,4 ]
机构：
[1] Inst Curie, Dept Drug Dev & Innovat D3I, 26 Rue Ulm, F-75005 Paris, France
[2] Inst Curie, Dept Drug Dev & Innovat D3I, St Cloud, France
[3] INSERM, U900, Res Unit, St Cloud, France
[4] Paris Saclay Univ, Dept Med, Paris, France
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2020年 / 8卷 / 23期
关键词：
SQUAMOUS-CELL CARCINOMA; EXPRESSION;
D O I：
10.21037/atm-20-2656
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 15 条
  • [1] Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review
    Boussios, Stergios
    Seraj, Esmeralda
    Zarkavelis, George
    Petrakis, Dimitrios
    Kollas, Aristomenes
    Kafantari, Aikaterini
    Assi, Abraam
    Tatsi, Konstantina
    Pavlidis, Nicholas
    Pentheroudakis, George
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 108 : 164 - 174
  • [2] Susceptibility to cervical cancer: An overview
    de Freitas, Antonio Carlos
    Almeida Diniz Gurgel, Ana Pavla
    Chagas, Barbara Simas
    Coimbra, Eliane Campos
    Medeiros do Amaral, Carolina Maria
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 126 (02) : 304 - 311
  • [3] Frenel JS, 2017, J CLIN ONCOL ANN TRA, V8, P1611, DOI [10.21037/atm-20-26562017
  • [4] 35:4035-41, DOI 10.21037/ATM-20-26562017
  • [5] 35:4035-41]
  • [6] Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix
    Heeren, A. Marijne
    Punt, Simone
    Bleeker, Maaike C. G.
    Gaarenstroom, Katja N.
    van der Velden, Jacobus
    Kenter, Gemma G.
    de Gruijl, Tanja D.
    Jordanova, Ekaterina S.
    [J]. MODERN PATHOLOGY, 2016, 29 (07) : 753 - 763
  • [7] Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus-Related Cervical Carcinoma
    Lheureux, Stephanie
    Butler, Marcus O.
    Clarke, Blaise
    Cristea, Mihaela C.
    Martin, Lainie P.
    Tonkin, Katia
    Fleming, Gini F.
    Tinker, Anna V.
    Hirte, Hal W.
    Tsoref, Daliah
    Mackay, Helen
    Dhani, Neesha C.
    Ghatage, Prafull
    Weberpals, Johanne
    Welch, Stephen
    Pham, Nhu-An
    Motta, Vinicius
    Sotov, Valentin
    Wang, Lisa
    Karakasis, Katherine
    Udagani, Smitha
    Kamel-Reid, Suzanne
    Streicher, Howard Z.
    Shaw, Patricia
    Oza, Amit M.
    [J]. JAMA ONCOLOGY, 2018, 4 (07)
  • [8] Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers
    Mezache, Louisa
    Paniccia, Bernard
    Nyinawabera, Angelique
    Nuovo, Gerard J.
    [J]. MODERN PATHOLOGY, 2015, 28 (12) : 1594 - 1602
  • [9] Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A gynecologic oncology group study
    Moore, DH
    Blessing, JA
    McQuellon, RP
    Thaler, HT
    Cella, D
    Benda, J
    Miller, DS
    Olt, G
    King, S
    Boggess, JF
    Rocereto, TF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) : 3113 - 3119
  • [10] Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial
    Naumann, R. Wendel
    Hollebecque, Antoine
    Meyer, Tim
    Devlin, Michael-John
    Oaknin, Ana
    Kerger, Joseph
    Lopez-Picazo, Jose M.
    Machiels, Jean-Pascal
    Delord, Jean-Pierre
    Evans, Thomas R. J.
    Boni, Valentina
    Calvo, Emiliano
    Topalian, Suzanne L.
    Chen, Tian
    Soumaoro, Ibrahima
    Li, Bin
    Gu, Junchen
    Zwirtes, Ricardo
    Moore, Kathleen N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31) : 2825 - +
12